Rahmi, Dina,Tjandrawinata, Raymond R.,Arifin, Poppy Firzani,Aripin, Asep
申请号：
AU2009261597
公开号：
AU2009261597B2
申请日:
2009.06.08
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
A pharmaceutical dosage form consisting of an extract of Phaleria macrocarpa which has antineoplastic, anti-inflammatory and antiangiogenic activity. Its use as an antineoplastic agent is to inhibit tumour growth. Its use as an anti-inflammatory agent is to relieve inflammation and pain, and also as an antipyretic. Another use is as an antiangiogenic agent to inhibit the growth of new blood vessels to prevent cancer metastasis.
